ASA
COV

Armstrong Shaw Associates’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Armstrong Shaw Associates’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-79,568
Closed -$8.14M – 42
2014
Q4 		$8.14M Sell
79,568
-37,977
-32% -$3.64M 1.47% 34
2014
Q3 		$10.2M Sell
117,545
-3,524
-3% -$312K 1.85% 30
2014
Q2 		$10.9M Sell
121,069
-219,384
-64% -$16.4M 1.97% 30
2014
Q1 		$25.1M Sell
340,453
-788,859
-70% -$55M 3.08% 12
2013
Q4 		$76.9M Sell
1,129,312
-3,782
-0.3% -$246K 2.84% 18
2013
Q3 		$69.1M Sell
1,133,094
-150,271
-12% -$9.17M 2.8% 17
2013
Q2 		$71.5M Buy
+1,283,365
New +$74.2M 2.98% 11

Armstrong Shaw Associates's COV Position: Q1 2015 in Review

Armstrong Shaw Associates sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 79,568 shares — an estimated $8.14M sold.

Armstrong Shaw Associates first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $76.9M in Q4 2013. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Armstrong Shaw Associates reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Armstrong Shaw Associates sold 79,568 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $8.14M.
  • Armstrong Shaw Associates first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Armstrong Shaw Associates's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $76.9M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Armstrong Shaw Associates's 13F filing for Q1 2015, filed 11 May 2015.